Share buy-back week 25/2017

Announcement              26 June 2017   Coloplast – transactions in connection with share buy-back programme  As mentioned in Announcement No. 2/2017 Coloplast has initiated the second part of the share buy-back programme totalling up to DKK 1bn. This part of the programme of DKK500m is expected to … [Read more...]

Positive Phase 1b Data for NewLink Genetics’ IDO Pathway Inhibitor, Indoximod, in Combination with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Presented at the European Hematologic Association (EHA) Congress in Madrid, Spain

AMES, Iowa, June 23, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced the presentation of data from the Phase 1b portion of a study of indoximod, an IDO pathway inhibitor, in combination with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia (AML).  Abstract E-912, Indoximod in Combination with Idarubicin and … [Read more...]

Lundbeck and Takeda receive Complete Response Letter from the FDA for Trintellix® (vortioxetine) sNDA

Valby, Denmark and Osaka, Japan, 23 June 2017 - H. Lundbeck A/S (Lundbeck) and Takeda Pharmaceutical Company Limited (Takeda) today announced that after providing additional analysis, the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the supplemental new drug application (sNDA) to include new data in the clinical trials section of … [Read more...]

Noblegen Announces the Opening of Its Second Round of Financing: Peterborough-based biotechnology startup targeting up to $50 million in equity financing

PETERBOROUGH, Ontario, June 22, 2017 (GLOBE NEWSWIRE) -- Today Peterborough based Noblegen announces the opening of its series B round of financing after the closing of a successful series A round that saw the firm raise $9.5 million in private investment. A photo accompanying this announcement is available at … [Read more...]

Vladimirs Krusinskis Appointed As the New Board Member of Olainfarm

Olaine, 2017-06-22 14:50 CEST (GLOBE NEWSWIRE) -- Vladimirs Krusinskis is a Director of Tehcnical Department of AS “Olainfarm”, having more than 15 years of experience in industrial companies. Mr. Krusinskis joined Olainfarm in 2012. His previous career included AS “Rigas Farmaceitiska Fabrika”. Vladimirs Krusinskis has a degree of Bachelor of Engineering. Mr. Krusinskis owns … [Read more...]